{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:16:27Z","timestamp":1792671387765,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.idc.2008.03.011","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T09:11:44Z","timestamp":1219828304000},"page":"433-448","source":"Crossref","is-referenced-by-count":129,"title":["Human Granulocytic Anaplasmosis"],"prefix":"10.1016","volume":"22","author":[{"given":"Johan S.","family":"Bakken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Dumler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2008.03.011_bib1","first-page":"65","article-title":"What a revelation any science is!","volume":"71","author":"Margulis","year":"2005","journal-title":"ASM News"},{"key":"10.1016\/j.idc.2008.03.011_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1001\/jama.1994.03520030054028","article-title":"Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?","volume":"272","author":"Bakken","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2008.03.011_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199907153410303","article-title":"Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis","volume":"341","author":"Buller","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s100960000415","article-title":"Arthropod-borne spirochetoses: a historical perspective","volume":"20","author":"Burgdorfer","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1126\/science.769166","article-title":"Human babesiosis: reservoir in infection on Nantucket Island","volume":"192","author":"Healy","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.idc.2008.03.011_bib6","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM198704023161406","article-title":"Human infection with Ehrlichia canis, a leukocytic rickettsia","volume":"316","author":"Maeda","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.idc.2008.03.011_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/JCM.32.3.589-595.1994","article-title":"Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease","volume":"32","author":"Chen","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199601253340401","article-title":"Direct cultivation of the causative agent of human granulocytic ehrlichiosis","volume":"334","author":"Goodman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib10","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1128\/JCM.41.9.4328-4335.2003","article-title":"Isolation of an Anaplasma sp. organism from white-tailed deer by tick cell culture","volume":"41","author":"Munderloh","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-1097(03)00687-6","article-title":"Anaplasma phagocytophilum major surface protein-2 (Msp2) forms multimeric complexes in the bacterial membrane","volume":"227","author":"Park","year":"2003","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.idc.2008.03.011_bib12","series-title":"Tick-borne infectious diseases. Diagnosis and management","first-page":"139","article-title":"Ehrlichiosis","author":"Bakken","year":"2000"},{"key":"10.1016\/j.idc.2008.03.011_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM200107123450207","article-title":"Lyme disease","volume":"345","author":"Steere","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0025-7125(03)00092-0","article-title":"Babesiosis","volume":"86","author":"Krause","year":"2002","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.idc.2008.03.011_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1996.03530270039029","article-title":"Clinical and laboratory characteristics of human granulocytic ehrlichiosis","volume":"275","author":"Bakken","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2008.03.011_bib16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2460\/javma.2003.223.1750","article-title":"Ehrlichiosis and related infections","volume":"223","author":"McQuiston","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.idc.2008.03.011_bib17","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/JCM.40.7.2612-2615.2002","article-title":"Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York","volume":"40","author":"Aguero-Rosenfeld","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1086\/515048","article-title":"Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin","volume":"27","author":"Bakken","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3201\/eid0505.990504","article-title":"The human ehrlichioses in the United States","volume":"5","author":"McQuiston","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib20","first-page":"433","article-title":"Ehrlichiosis and anaplasmosis","volume":"21","author":"Bakken","year":"2004","journal-title":"Infect Med"},{"key":"10.1016\/j.idc.2008.03.011_bib21","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/324517","article-title":"Population-based incidence of human granulocytic ehrlichiosis in northwestern Wisconsin, 1997\u20131999","volume":"184","author":"Belongia","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1374.042","article-title":"Clinical diagnosis and treatment of human granulocytotropic anaplasmosis","volume":"1078","author":"Bakken","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.idc.2008.03.011_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1469-0691.2002.00557.x","article-title":"Human granulocytic ehrlichiosis in Europe","volume":"8","author":"Blanco","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idc.2008.03.011_bib24","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/JCM.35.6.1556-1559.1997","article-title":"Human disease in Europe caused by a granulocytic Ehrlichia species","volume":"35","author":"Petrovec","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-125-11-199612010-00006","article-title":"Human granulocytic ehrlichiosis: a case series from a medical center in New York State","volume":"125","author":"Aguero-Rosenfeld","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2008.03.011_bib26","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/515000","article-title":"Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases","volume":"27","author":"Horowitz","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM199808063390604","article-title":"Perinatal transmission of the agent of human granulocytic ehrlichiosis","volume":"339","author":"Horowitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/clinids\/23.1.198","article-title":"Exposure to deer blood may be a cause of human granulocytic ehrlichiosis","volume":"23","author":"Bakken","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib29","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.38.6.2398-2399.2000","article-title":"Survival of the human granulocytic ehrlichiosis agent under refrigeration conditions","volume":"38","author":"Kalantarpour","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib30","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1046\/j.1537-2995.2002.00251.x","article-title":"Relationship between tick bites and the seroprevalence of Babesia microti and Anaplasma phagocytophila (previously Ehrlichia sp.) in blood donors","volume":"42","author":"Leiby","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.idc.2008.03.011_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0025-7125(03)00083-X","article-title":"The natural history of ticks","volume":"86","author":"Anderson","year":"2002","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.idc.2008.03.011_bib32","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0002-9343(99)80038-2","article-title":"Environmental risk and prevention of Lyme disease","volume":"98","author":"Fish","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib33","first-page":"338","article-title":"The ecology of Lyme disease risk","volume":"85","author":"Ostfeld","year":"1997","journal-title":"Am Sci"},{"key":"10.1016\/j.idc.2008.03.011_bib34","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1073\/pnas.93.12.6209","article-title":"Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle","volume":"93","author":"Telford","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.idc.2008.03.011_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3201\/eid0705.017517","article-title":"Ehrlichia-infected ticks on migrating birds","volume":"7","author":"Bjoersdorff","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib36","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/JCM.35.6.1465-1468.1997","article-title":"Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin","volume":"35","author":"Belongia","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib37","doi-asserted-by":"crossref","first-page":"266","DOI":"10.7589\/0090-3558-35.2.266","article-title":"Infections of granulocytic ehrlichiae and Borrelia burgdorferi in white-tailed deer in Connecticut","volume":"35","author":"Magnarelli","year":"1999","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3201\/eid0401.980113","article-title":"Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County","volume":"4","author":"Varde","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib39","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/JCM.37.9.2887-2892.1999","article-title":"Infection with agents of human granulocytic ehrlichiosis, Lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut","volume":"37","author":"Stafford","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib40","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1128\/JCM.34.3.724-727.1996","article-title":"Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota","volume":"34","author":"Mitchell","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/infdis\/175.3.720","article-title":"A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden","volume":"175","author":"Dumler","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib42","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1086\/313948","article-title":"Human granulocytic ehrlichiosis","volume":"31","author":"Bakken","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/clinids\/21.4.910","article-title":"Human granulocytic ehrlichiosis in Connecticut: report of a fatal case","volume":"21","author":"Hardalo","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib44","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/clinids\/27.5.1323","article-title":"Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis","volume":"27","author":"Bakken","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib45","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.46.4.1026","article-title":"Brachial plexopathy associated with human granulocytic ehrlichiosis","volume":"46","author":"Horowitz","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.idc.2008.03.011_bib46","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/515014","article-title":"Fatal pancarditis associated with human granulocytic ehrlichiosis in a 44-year-old man","volume":"27","author":"Jahangir","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4269\/ajtmh.2000.62.29","article-title":"Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections","volume":"62","author":"Lepidi","year":"2000","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2008.03.011_bib48","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.moh.0000190109.00532.56","article-title":"Mechanisms of evasion of neutrophil killing by Anaplasma phagocytophilum","volume":"13","author":"Carlyon","year":"2006","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.idc.2008.03.011_bib49","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1128\/IAI.71.10.5650-5661.2003","article-title":"Mechanisms of variable p44 expression by Anaplasma phagocytophilum","volume":"71","author":"Lin","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2008.03.011_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1462-5822.2005.00643.x","article-title":"Differential expression of VirB9 and VirB6 during the life cycle of Anaplasma phagocytophilum in human leucocytes is associated with differential binding and avoidance of lysosome pathway","volume":"8","author":"Niu","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib51","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.3201\/eid1112.050898","article-title":"Human granulocytic anaplasmosis and Anaplasma phagocytophilum","volume":"11","author":"Dumler","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib52","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.1128\/IAI.73.12.8209-8218.2005","article-title":"Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway","volume":"73","author":"Choi","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.idc.2008.03.011_bib53","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64145-4","article-title":"Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis","volume":"158","author":"Martin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.idc.2008.03.011_bib54","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1086\/386284","article-title":"Anaplasma phagocytophilum ligation to Toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor- kappa B nuclear translocation","volume":"189","author":"Choi","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib55","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1128\/CVI.00204-07","article-title":"Mitogenic component in polar lipid-enriched Anaplasma phagocytophilum membranes","volume":"14","author":"Choi","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.idc.2008.03.011_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/518834","article-title":"Human granulocytic anaplasmosis and macrophage activation","volume":"45","author":"Dumler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib57","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1086\/319350","article-title":"Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis","volume":"32","author":"Bakken","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib58","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JCM.41.2.717-722.2003","article-title":"Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum","volume":"41","author":"Massung","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/153036602321653815","article-title":"Diagnosis of human granulocytic ehrlichiosis: state of the art","volume":"2","author":"Aguero-Rosenfeld","year":"2002","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib60","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1086\/323811","article-title":"The serological response of patients infected with the agent of human granulocytic ehrlichiosis","volume":"34","author":"Bakken","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib61","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1086\/320160","article-title":"Tickborne infections as a cause of nonspecific febrile illness in Wisconsin","volume":"32","author":"Belongia","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib62","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/JCM.37.9.2968-2973.1999","article-title":"Inter- and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test","volume":"37","author":"Walls","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1473-3099(09)70296-8","article-title":"Tick-borne ehrlichioses","volume":"1","author":"Dumler","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib64","first-page":"287","article-title":"Diagnosing human ehrlichioses: current status and recommendations","volume":"5","author":"Walker","year":"2000","journal-title":"Am Society Microbiol News"},{"key":"10.1016\/j.idc.2008.03.011_bib65","series-title":"International classification of diseases. The World Wide Web 9th Revision, Clinical Modification(6th)","author":"Anonymous","year":"2002"},{"key":"10.1016\/j.idc.2008.03.011_bib66","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1128\/AAC.45.3.786-788.2001","article-title":"Antimicrobial susceptibility of Ehrlichia phagocytophila","volume":"45","author":"Horowitz","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2008.03.011_bib67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/AAC.41.1.76","article-title":"Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins","volume":"41","author":"Klein","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2008.03.011_bib68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/AAC.47.1.413-415.2003","article-title":"Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States","volume":"47","author":"Maurin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2008.03.011_bib69","series-title":"Antimicrobial therapy and vaccine","first-page":"875","article-title":"Ehrlichia and Anaplasma species","author":"Bakken","year":"2002"},{"key":"10.1016\/j.idc.2008.03.011_bib70","series-title":"Red book: 2003 report of the committee of infectious diseases","first-page":"266","article-title":"Ehrlichia infections (human ehrlichioses)","author":"Anonymous","year":"2003"},{"key":"10.1016\/j.idc.2008.03.011_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1196\/annals.1355.069","article-title":"Anaplasma and ehrlichia infection","volume":"1063","author":"Dumler","year":"2005","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.idc.2008.03.011_bib72","series-title":"AHFS drug information","first-page":"433","article-title":"Tetracyclines","author":"Anonymous","year":"2004"},{"key":"10.1016\/j.idc.2008.03.011_bib73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1086\/517678","article-title":"Human granulocytic ehrlichiosis during pregnancy treated successfully with rifampin","volume":"27","author":"Buitrago","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib74","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199812243392615","article-title":"Perinatal transmission of human granulocytic ehrlichiosis","volume":"339","author":"Elston","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2008.03.011_bib75","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1542\/peds.112.3.e252","article-title":"Successful treatment of human granulocytic ehrlichiosis in children using rifampin","volume":"112","author":"Krause","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.idc.2008.03.011_bib76","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/vbz.2006.6.388","article-title":"Dissociation between inhibition and killing by levofloxacin in human granulocytic anaplasmosis","volume":"6","author":"Wormser","year":"2006","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2008.03.011_bib77","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/518146","article-title":"Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment","volume":"45","author":"Dumler","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib78","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4269\/ajtmh.2005.73.400","article-title":"Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001\u20132002","volume":"73","author":"Demma","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.idc.2008.03.011_bib79","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/313532","article-title":"Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin","volume":"29","author":"Belongia","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib80","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3201\/eid0804.010222","article-title":"Outcomes of treated human granulocytic ehrlichiosis cases","volume":"8","author":"Ramsey","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2008.03.011_bib81","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.158.7.769","article-title":"Human granulocytic ehrlichiosis in New York","volume":"158","author":"Wallace","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2008.03.011_bib82","first-page":"4200","volume":"96","author":"Bjoersdorff","year":"1999","journal-title":"Lakartidningen"},{"key":"10.1016\/j.idc.2008.03.011_bib83","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-129-6-199809150-00007","article-title":"Reinfection with the agent of human granulocytic ehrlichiosis","volume":"129","author":"Horowitz","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idc.2008.03.011_bib84","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1128\/JCM.33.12.3333-3334.1995","article-title":"Protection against Ehrlichia equi is conferred by prior infection with the human granulocytotropic Ehrlichia (HGE agent)","volume":"33","author":"Barlough","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2008.03.011_bib85","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1172\/JCI119855","article-title":"Immunization against the agent of human granulocytic ehrlichiosis in a murine model","volume":"100","author":"Sun","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.idc.2008.03.011_bib86","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1086\/517829","article-title":"Duration of tick attachment required for transmission of granulocytic ehrlichiosis","volume":"177","author":"Katavolos","year":"1998","journal-title":"J Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552008000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552008000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T23:25:14Z","timestamp":1588893914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552008000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0891552008000159"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2008.03.011","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}